Healthcare provider profile · identity verified

Jon Kyle Melvin, MD

Family Practice · SILER CITY, NC · NPI 1770071292

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	498	119
Amlodipine Besylate	Amlodipine Besylate	314	78
Gabapentin	Gabapentin	287	69
Omeprazole	Omeprazole	260	63
Furosemide	Furosemide	237	58
Levothyroxine Sodium	Levothyroxine Sodium	228	53
Losartan Potassium	Losartan Potassium	228	62
Metoprolol Succinate	Metoprolol Succinate	216	50
Pantoprazole Sodium	Pantoprazole Sodium	208	51
Lisinopril	Lisinopril	207	56
Trazodone Hcl	Trazodone Hcl	184	47
Albuterol Sulfate Hfa	Albuterol Sulfate	181	55
Rosuvastatin Calcium	Rosuvastatin Calcium	169	45
Ezetimibe	Ezetimibe	157	36
Eliquis	Apixaban	142	32
Carvedilol	Carvedilol	138	31
Tamsulosin Hcl	Tamsulosin Hcl	138	38
Metformin Hcl	Metformin Hcl	137	33
Fluticasone Propionate	Fluticasone Propionate	129	48
Sertraline Hcl	Sertraline Hcl	122	27
Mirtazapine	Mirtazapine	112	22
Ozempic	Semaglutide	109	26
Hydrochlorothiazide	Hydrochlorothiazide	107	33
Clopidogrel	Clopidogrel Bisulfate	96	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	95	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	95	23
Metformin Hcl Er	Metformin Hcl	94	23
Duloxetine Hcl	Duloxetine Hcl	88	22
Jardiance	Empagliflozin	87	24
Valsartan	Valsartan	87	21
Potassium Chloride	Potassium Chloride	83	21
Bupropion Xl	Bupropion Hcl	81	20
Nystatin	Nystatin	81	20
Oxycodone Hcl	Oxycodone Hcl	79	21
Metoprolol Tartrate	Metoprolol Tartrate	76	23
Atenolol	Atenolol	75	18
Glipizide Er	Glipizide	71	19
Prednisone	Prednisone	64	33
Spironolactone	Spironolactone	59	14
Allopurinol	Allopurinol	56	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	54	suppressed
Ropinirole Hcl	Ropinirole Hcl	53	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	52	suppressed
Meloxicam	Meloxicam	52	12
Esomeprazole Magnesium	Esomeprazole Magnesium	51	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	49	suppressed
Januvia	Sitagliptin Phosphate	46	suppressed
Buspirone Hcl	Buspirone Hcl	45	11
Bumetanide	Bumetanide	44	suppressed
Pravastatin Sodium	Pravastatin Sodium	44	15
Pregabalin	Pregabalin	43	suppressed
Topiramate	Topiramate	41	suppressed
Warfarin Sodium	Warfarin Sodium	41	suppressed
Ibuprofen	Ibuprofen	40	11
Famotidine	Famotidine	39	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	11
Montelukast Sodium	Montelukast Sodium	38	suppressed
Tramadol Hcl	Tramadol Hcl	38	suppressed
Hydralazine Hcl	Hydralazine Hcl	37	suppressed
Synthroid	Levothyroxine Sodium	37	suppressed
Clonazepam	Clonazepam	36	11
Enalapril Maleate	Enalapril Maleate	36	suppressed
Meclizine Hcl	Meclizine Hcl	35	13
Amitriptyline Hcl	Amitriptyline Hcl	34	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	34	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	suppressed
Morphine Sulfate Er	Morphine Sulfate	33	suppressed
Simvastatin	Simvastatin	33	suppressed
Alprazolam	Alprazolam	30	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	28	24
Finasteride	Finasteride	28	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Klor-Con M20	Potassium Chloride	27	suppressed
Nitroglycerin	Nitroglycerin	27	11
Valacyclovir	Valacyclovir Hcl	27	suppressed
Alendronate Sodium	Alendronate Sodium	26	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	26	suppressed
Cephalexin	Cephalexin	26	24
Glipizide	Glipizide	26	suppressed
Hydrocortisone	Hydrocortisone	26	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	23
Donepezil Hcl	Donepezil Hcl	25	suppressed
Lactulose	Lactulose	25	suppressed
Ondansetron Odt	Ondansetron	25	13
Ramipril	Ramipril	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Arnuity Ellipta	Fluticasone Furoate	24	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Lacosamide	Lacosamide	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	23	suppressed
Methocarbamol	Methocarbamol	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Baclofen	Baclofen	20	suppressed
Olanzapine	Olanzapine	20	suppressed
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Dutasteride	Dutasteride	15	suppressed
Levofloxacin	Levofloxacin	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Tresiba Flextouch U-200	Insulin Degludec	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Torsemide	Torsemide	14	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Methadone Hcl	Methadone Hcl	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Azithromycin	Azithromycin	12	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Febuxostat	Febuxostat	12	suppressed
Fetzima	Levomilnacipran Hcl	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Diazepam	Diazepam	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Oxcarbazepine	Oxcarbazepine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error